Cardiovascular effects of levosimendan in the early stages of endotoxemia

Shock

Volumn 28, Issue 1, 2007, Pages 71-77

  Cunha Goncalves, Doris ^a,b   Perez De Sa, Valeria ^a   Dahm, Peter ^a   Grins, Edgars ^a   Thörne, Johan ^a   Blomquist, Sten ^a  

^a LUND UNIVERSITY   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Cardiotonic agents; Coronary circulation; Lactates; Myocardial oxygen consumption; Sepsis; Swine

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; CALCIUM SENSITIZER; LACTIC ACID; LEVOSIMENDAN; OXYGEN; PLACEBO;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD SAMPLING; CALORIMETRY; CARDIOVASCULAR SYSTEM; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY VASCULAR RESISTANCE; DRUG EFFECT; ENDOTOXEMIA; ESCHERICHIA COLI; FEMALE; HEART MUSCLE BLOOD FLOW; HEART MUSCLE ISCHEMIA; HEART OUTPUT; HEART RATE; HEMODYNAMICS; HYPOTENSION; INDWELLING CATHETER; MEAN ARTERIAL PRESSURE; NONHUMAN; OXYGEN CONSUMPTION; PROSPECTIVE STUDY; PULMONARY HYPERTENSION; RANDOMIZATION; STATISTICAL SIGNIFICANCE; SWINE; SYSTEMIC VASCULAR RESISTANCE; TACHYCARDIA; THERMODILUTION; VASODILATATION;

ANIMALS; CALCIUM; CARDIOTONIC AGENTS; CORONARY CIRCULATION; ENDOTOXEMIA; FEMALE; HYDRAZONES; LIPOPOLYSACCHARIDES; MYOCARDIUM; OXYGEN CONSUMPTION; PULMONARY CIRCULATION; PYRIDAZINES; SUS SCROFA; TIME FACTORS;

EID: 34250757623     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/shk.0b013e31804d18f6     Document Type: Article

References (25)

1. Dellinger RP: Cardiovascular management of septic shock. Crit Care Med 31:946-955, 2003.
2. Pagel PS, Kersten JR, Warltier DC: Cardiovascular pharmacology of positive inotropic drugs. In: Evers AS, Maze M (eds.): Anesthetic Pharmacology: Physiologic Principles and Clinical Practice. Philadelphia, PA: Churchill Livingstone-Elsevier, pp. 655-670, 2004.
3. 2+ in cardiac myocytes. Circ Res 81:1011-1020, 1997.
4. Matejovic M, Krouzecky A, Radej J, Novak I: Successful reversal of resistant hypodynamic septic shock with levosimendan. Acta Anaesthesiol Scand 49:127-128, 2005.
5. Morelli A, De Castro S, Teboul JL, Singer M, Rocco M, Conti G, De Luca L, Di Angelantonio E, Orecchioni A, Pandian NG, et al.: Effects of levosimendan on systemic and regional hemodynamics in septic myocardial depression. Intensive Care Med 31:638-644, 2005.
6. Oldner A, Konrad D, Weitzberg E, Rudehill A, Rossi P, Wanecek M: Effects of levosimendan, a novel inotropic calcium-sensitizing drug, in experimental septic shock. Crit Care Med 29:2185-2193, 2001.
7. Haikala H, Kaivola J, Nissinen E, Wall P, Levijoki J, Linden IB: Cardiac troponin C as a target protein for a novel calcium sensitizing drug, levosimendan. J Mol Cell Cardiol 27:1859-1866, 1995.
8. Todaka K, Wang J, Yi GH, Stennett R, Knecht M, Packer M, Burkhoff D: Effects of levosimendan on myocardial contractility and oxygen consumption. J Pharmacol Exp Ther 279:120-127, 1996.
9. Gruhn N, Nielsen-Kudsk JE, Theilgaard S, Bang L, Olesen SP, Aldershvile J: Coronary vasorelaxant effect of levosimendan, a new inodilator with calcium-sensitizing properties. J Cardiovasc Pharmacol 31:741-749, 1998.
10. De Witt BJ, Ibrahim IN, Bayer E, Fields AM, Richards TA, Banister RE, Kaye AD: An analysis of responses to levosimendan in the pulmonary vascular bed of the cat. Anesth Analg 94:1427-1433, 2002.
11. + channel in rat arterial myocytes. Eur J Pharmacol 333:249-259, 1997.
12. Moiseyev VS, Poder P, Andrejevs N, Ruda MY, Golikov AP, Lazebnik LB, Kobalava ZD, Lehtonen LA, Laine T, Nieminen MS, et al.: Safety and efficacy of a novel calcium sensitizer, levosimendan, in patients with left ventricular failure due to an acute myocardial infarction. A randomized, placebo-controlled, double-blind study (RUSSLAN). Eur Heart J 23:1422-1432, 2002.
13. Leather HA, Ver Eycken K, Segers P, Herijgers P, Vandermeersch E, Wouters PF: Effects of levosimendan on right ventricular function and ventriculovascular coupling in open chest pigs. Crit Care Med 31:2339-2343, 2003.
14. Ganz W, Tamura K, Marcus HS, Donoso R, Yoshida S, Swan HJ: Measurement of coronary sinus blood flow by continuous thermodilution in man. Circulation 44:181-195, 1971.
15. Perez-de-Sa V, Roscher R, Cunha-Goncalves D, Larsson A, Werner O: Mild hypothermia has minimal effects on the tolerance to severe progressive normovolemic anemia in swine. Anesthesiology 97:1189-1197, 2002.
16. Aghajani E, Korvald C, Nordhaug D, Sager G, Revhaug A, Myrmel T: E. coli sepsis induces profound mechanoenergetic inefficiency in the porcine left ventricle. Shock 21:103-109, 2004.
17. Ukkonen H, Saraste M, Akkila J, Knuuti J, Karanko M, Iida H, Lehikoinen P, Nagren K, Lehtonen L, Voipio-Pulkki LM: Myocardial efficiency during levosimendan infusion in congestive heart failure. Clin Pharmacol Ther 68:522-531, 2000.
18. Tassani P, Schad H, Heimisch W, Bernhard-Abt A, Ettner U, Mendler N, Lange R: Effect of the calcium sensitizer levosimendan on the performance of ischaemic myocardium in anaesthetised pigs. Cardiovasc Drugs Ther 16:435-441, 2002.
19. 2+ sensitivity of cardiac myofibrils and sarcoplasmic reticulum in guinea pig heart. Circ Res 77:107-113, 1995.
20. Kivikko M, Lehtonen L, Colucci WS: Sustained hemodynamic effects of intravenous levosimendan. Circulation 107:81-86, 2003.
21. Behrends M, Peters J: The calcium sensitizer levosimendan attenuates endotoxin-evoked myocardial dysfunction in isolated guinea pig hearts. Intensive Care Med 29:1802-1807, 2003.
22. Szilagyi S, Pollesello P, Levijoki J, Haikala H, Bak I, Tosaki A, Borbely A, Edes I, Papp Z: Two inotropes with different mechanisms of action: contractile, PDE-inhibitory and direct myofibrillar effects of levosimendan and enoximone. J Cardiovasc Pharmacol 46:369-376, 2005.
23. Maury P, Baixas C, Roncalli J, Couderc P, Delay M, Pathak A, Galinier M: Resumption of atrioventricular conduction by levosimendan after radio-frequency ablation of the AV node. Pacing Clin Electrophysiol 27:1314-1316, 2004.
24. Vincent JL, Gerlach H: Fluid resuscitation in severe sepsis and septic shock: an evidence-based review. Crit Care Med 32:S451-S454, 2004.
25. Marshall JC, Deitch E, Moldawer LL, Opal S, Redl H, van der Poll T: Preclinical models of shock and sepsis: what can they tell us? Shock 24(suppl 1):1-6, 2005.